Drugs / Vicks VapoInhaler
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01736332 | Jul 2012 → Jan 2014 | — | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vicks VapoInhaler | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01736332 ↗ |
| Route | Intranasal | “administered intranasally” NCT01736332 ↗ |